Cargando…
Efficacy of long‐term adrenocorticotropic hormone therapy for West syndrome: A retrospective multicenter case series
OBJECTIVES: Long‐term adrenocorticotropic therapy (LT‐ACTH), which consisted of 2‐4 weeks of daily injections of adrenocorticotropic hormone (ACTH) and subsequent months of weekly injections, was tried for relapsed West syndrome (WS) or other intractable epilepsies in small case reports. Our aim was...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166796/ https://www.ncbi.nlm.nih.gov/pubmed/34095686 http://dx.doi.org/10.1002/epi4.12497 |
_version_ | 1783701572315774976 |
---|---|
author | Baba, Shimpei Okanishi, Tohru Homma, Yoichiro Yoshida, Takeshi Goto, Tomohide Fukasawa, Tatsuya Kobayashi, Satoru Kamei, Atsushi Fujii, Yuji Hino‐Fukuyo, Naomi Yamada, Keitaro Daida, Atsuro Kawawaki, Hisashi Hoshino, Hideki Sejima, Hitoshi Ishida, Yusuke Okazaki, Tetsuya Inui, Takehiko Kanai, Sotaro Motoi, Hirotaka Itamura, Shinji Nishimura, Mitsuyo Enoki, Hideo Fujimoto, Ayataka |
author_facet | Baba, Shimpei Okanishi, Tohru Homma, Yoichiro Yoshida, Takeshi Goto, Tomohide Fukasawa, Tatsuya Kobayashi, Satoru Kamei, Atsushi Fujii, Yuji Hino‐Fukuyo, Naomi Yamada, Keitaro Daida, Atsuro Kawawaki, Hisashi Hoshino, Hideki Sejima, Hitoshi Ishida, Yusuke Okazaki, Tetsuya Inui, Takehiko Kanai, Sotaro Motoi, Hirotaka Itamura, Shinji Nishimura, Mitsuyo Enoki, Hideo Fujimoto, Ayataka |
author_sort | Baba, Shimpei |
collection | PubMed |
description | OBJECTIVES: Long‐term adrenocorticotropic therapy (LT‐ACTH), which consisted of 2‐4 weeks of daily injections of adrenocorticotropic hormone (ACTH) and subsequent months of weekly injections, was tried for relapsed West syndrome (WS) or other intractable epilepsies in small case reports. Our aim was to explore the efficacy of LT‐ACTH for preventing WS relapse, as well as the prevalence of its adverse events. METHODS: This is a retrospective, nationwide, multicenter case series of patients with WS who underwent LT‐ACTH. Clinical information of the patients and protocol of LT‐ACTH were collected from participating institutes in this study. We defined clinical response to ACTH as achievement of hypsarrhythmia and epileptic spasms resolution. Patients who responded to daily ACTH injections were identified and assessed whether they experienced WS relapse during/after the weekly ACTH injection period. The outcome was measured by the nonrelapse rate at 24 months after daily ACTH injections using the Kaplan‐Meier method. RESULTS: Clinical information of 16 children with WS was analyzed. The median age at LT‐ACTH initiation was 14.5 months (range: 7‐68 months). Thirteen (81%) patients had previously undergone conventional ACTH treatment. The LT‐ACTH regimens comprised a median of 16 days of daily injections (range: 11‐28 days) and 10 months of weekly injections (range: 3‐22 months). Seven patients experienced WS relapse during/after subsequent weekly ACTH period, and the nonrelapse rate at 24 months after daily injections was estimated at 60.6% (95% confidence interval: 32.3%‐80.0%). Height stagnation, hypertension, and irritability were observed; lethal adverse events were not reported. SIGNIFICANCE: Our study firstly explored the efficacy of LT‐ACTH for preventing WS relapse. LT‐ACTH might be a treatment option for patients with relapsed or intractable WS; however, we note that our study is limited by its small sample size and the lack of an appropriate control group. |
format | Online Article Text |
id | pubmed-8166796 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81667962021-06-05 Efficacy of long‐term adrenocorticotropic hormone therapy for West syndrome: A retrospective multicenter case series Baba, Shimpei Okanishi, Tohru Homma, Yoichiro Yoshida, Takeshi Goto, Tomohide Fukasawa, Tatsuya Kobayashi, Satoru Kamei, Atsushi Fujii, Yuji Hino‐Fukuyo, Naomi Yamada, Keitaro Daida, Atsuro Kawawaki, Hisashi Hoshino, Hideki Sejima, Hitoshi Ishida, Yusuke Okazaki, Tetsuya Inui, Takehiko Kanai, Sotaro Motoi, Hirotaka Itamura, Shinji Nishimura, Mitsuyo Enoki, Hideo Fujimoto, Ayataka Epilepsia Open Full‐length Original Research OBJECTIVES: Long‐term adrenocorticotropic therapy (LT‐ACTH), which consisted of 2‐4 weeks of daily injections of adrenocorticotropic hormone (ACTH) and subsequent months of weekly injections, was tried for relapsed West syndrome (WS) or other intractable epilepsies in small case reports. Our aim was to explore the efficacy of LT‐ACTH for preventing WS relapse, as well as the prevalence of its adverse events. METHODS: This is a retrospective, nationwide, multicenter case series of patients with WS who underwent LT‐ACTH. Clinical information of the patients and protocol of LT‐ACTH were collected from participating institutes in this study. We defined clinical response to ACTH as achievement of hypsarrhythmia and epileptic spasms resolution. Patients who responded to daily ACTH injections were identified and assessed whether they experienced WS relapse during/after the weekly ACTH injection period. The outcome was measured by the nonrelapse rate at 24 months after daily ACTH injections using the Kaplan‐Meier method. RESULTS: Clinical information of 16 children with WS was analyzed. The median age at LT‐ACTH initiation was 14.5 months (range: 7‐68 months). Thirteen (81%) patients had previously undergone conventional ACTH treatment. The LT‐ACTH regimens comprised a median of 16 days of daily injections (range: 11‐28 days) and 10 months of weekly injections (range: 3‐22 months). Seven patients experienced WS relapse during/after subsequent weekly ACTH period, and the nonrelapse rate at 24 months after daily injections was estimated at 60.6% (95% confidence interval: 32.3%‐80.0%). Height stagnation, hypertension, and irritability were observed; lethal adverse events were not reported. SIGNIFICANCE: Our study firstly explored the efficacy of LT‐ACTH for preventing WS relapse. LT‐ACTH might be a treatment option for patients with relapsed or intractable WS; however, we note that our study is limited by its small sample size and the lack of an appropriate control group. John Wiley and Sons Inc. 2021-05-28 /pmc/articles/PMC8166796/ /pubmed/34095686 http://dx.doi.org/10.1002/epi4.12497 Text en © 2021 The Authors. Epilepsia Open published by Wiley Periodicals LLC on behalf of International League Against Epilepsy https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Full‐length Original Research Baba, Shimpei Okanishi, Tohru Homma, Yoichiro Yoshida, Takeshi Goto, Tomohide Fukasawa, Tatsuya Kobayashi, Satoru Kamei, Atsushi Fujii, Yuji Hino‐Fukuyo, Naomi Yamada, Keitaro Daida, Atsuro Kawawaki, Hisashi Hoshino, Hideki Sejima, Hitoshi Ishida, Yusuke Okazaki, Tetsuya Inui, Takehiko Kanai, Sotaro Motoi, Hirotaka Itamura, Shinji Nishimura, Mitsuyo Enoki, Hideo Fujimoto, Ayataka Efficacy of long‐term adrenocorticotropic hormone therapy for West syndrome: A retrospective multicenter case series |
title | Efficacy of long‐term adrenocorticotropic hormone therapy for West syndrome: A retrospective multicenter case series |
title_full | Efficacy of long‐term adrenocorticotropic hormone therapy for West syndrome: A retrospective multicenter case series |
title_fullStr | Efficacy of long‐term adrenocorticotropic hormone therapy for West syndrome: A retrospective multicenter case series |
title_full_unstemmed | Efficacy of long‐term adrenocorticotropic hormone therapy for West syndrome: A retrospective multicenter case series |
title_short | Efficacy of long‐term adrenocorticotropic hormone therapy for West syndrome: A retrospective multicenter case series |
title_sort | efficacy of long‐term adrenocorticotropic hormone therapy for west syndrome: a retrospective multicenter case series |
topic | Full‐length Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166796/ https://www.ncbi.nlm.nih.gov/pubmed/34095686 http://dx.doi.org/10.1002/epi4.12497 |
work_keys_str_mv | AT babashimpei efficacyoflongtermadrenocorticotropichormonetherapyforwestsyndromearetrospectivemulticentercaseseries AT okanishitohru efficacyoflongtermadrenocorticotropichormonetherapyforwestsyndromearetrospectivemulticentercaseseries AT hommayoichiro efficacyoflongtermadrenocorticotropichormonetherapyforwestsyndromearetrospectivemulticentercaseseries AT yoshidatakeshi efficacyoflongtermadrenocorticotropichormonetherapyforwestsyndromearetrospectivemulticentercaseseries AT gototomohide efficacyoflongtermadrenocorticotropichormonetherapyforwestsyndromearetrospectivemulticentercaseseries AT fukasawatatsuya efficacyoflongtermadrenocorticotropichormonetherapyforwestsyndromearetrospectivemulticentercaseseries AT kobayashisatoru efficacyoflongtermadrenocorticotropichormonetherapyforwestsyndromearetrospectivemulticentercaseseries AT kameiatsushi efficacyoflongtermadrenocorticotropichormonetherapyforwestsyndromearetrospectivemulticentercaseseries AT fujiiyuji efficacyoflongtermadrenocorticotropichormonetherapyforwestsyndromearetrospectivemulticentercaseseries AT hinofukuyonaomi efficacyoflongtermadrenocorticotropichormonetherapyforwestsyndromearetrospectivemulticentercaseseries AT yamadakeitaro efficacyoflongtermadrenocorticotropichormonetherapyforwestsyndromearetrospectivemulticentercaseseries AT daidaatsuro efficacyoflongtermadrenocorticotropichormonetherapyforwestsyndromearetrospectivemulticentercaseseries AT kawawakihisashi efficacyoflongtermadrenocorticotropichormonetherapyforwestsyndromearetrospectivemulticentercaseseries AT hoshinohideki efficacyoflongtermadrenocorticotropichormonetherapyforwestsyndromearetrospectivemulticentercaseseries AT sejimahitoshi efficacyoflongtermadrenocorticotropichormonetherapyforwestsyndromearetrospectivemulticentercaseseries AT ishidayusuke efficacyoflongtermadrenocorticotropichormonetherapyforwestsyndromearetrospectivemulticentercaseseries AT okazakitetsuya efficacyoflongtermadrenocorticotropichormonetherapyforwestsyndromearetrospectivemulticentercaseseries AT inuitakehiko efficacyoflongtermadrenocorticotropichormonetherapyforwestsyndromearetrospectivemulticentercaseseries AT kanaisotaro efficacyoflongtermadrenocorticotropichormonetherapyforwestsyndromearetrospectivemulticentercaseseries AT motoihirotaka efficacyoflongtermadrenocorticotropichormonetherapyforwestsyndromearetrospectivemulticentercaseseries AT itamurashinji efficacyoflongtermadrenocorticotropichormonetherapyforwestsyndromearetrospectivemulticentercaseseries AT nishimuramitsuyo efficacyoflongtermadrenocorticotropichormonetherapyforwestsyndromearetrospectivemulticentercaseseries AT enokihideo efficacyoflongtermadrenocorticotropichormonetherapyforwestsyndromearetrospectivemulticentercaseseries AT fujimotoayataka efficacyoflongtermadrenocorticotropichormonetherapyforwestsyndromearetrospectivemulticentercaseseries |